Latest Cost Management News

Medical Developments International (MVP) reported an 8% revenue increase driven by strong Penthrox growth, despite a slight EBIT loss impacted by foreign exchange. The company advances pediatric approvals and targets further volume gains.

MA Financial Group reported a 36.1% rise in revenue and a 51.6% jump in net profit for 2025, while declaring a fully franked final dividend of 14 cents per share.

Prime Financial Group has reported a robust first half of FY26, with revenue climbing 31% and underlying EBITDA soaring 60%, driven by strategic acquisitions and organic growth.

Whitehaven Coal reported a 28% revenue decline to $2.48 billion and a net profit of $69 million for H1 FY26 amid softer coal prices and reduced equity sales. The company declared a fully franked 4 cent interim dividend and outlined ongoing development projects despite market headwinds.

IPH Limited reported a solid half-year performance with revenue up 6.5% to $363.9 million and net profit rising 10.5% to $41.2 million, driven by strong gains in Canada and Asia despite a decline in Australia and New Zealand.

Redox Limited has reported solid half-year results for December 2025, with revenue climbing 6.6% to $673.6 million and profit after tax increasing 8.9% to $43.8 million. The company declared a fully franked interim dividend of 6.5 cents per share, underscoring its financial strength amid dynamic market conditions.

NRW Holdings reported a robust first half of FY26, driven by strong segment performances and the strategic acquisition of Fredon Industries, boosting revenue and profits significantly.

Sandfire Resources Limited has delivered a strong H1 FY26 performance with record sales revenue and a return to a net cash position, while advancing key projects including the Kalkaroo Copper-Gold earn-in agreement.

APA Group has reported robust half-year results, boosting its organic growth pipeline to nearly $3 billion and reaffirming its full-year guidance amid ongoing cost reductions and strategic divestments.

Cogstate Limited reported a solid 12% increase in revenue to $26.9 million for the half-year ended December 2025, driven by growth in its Clinical Trials segment and a 2% rise in net profit before tax. The company’s contracted future Clinical Trials revenue also grew 10%, signalling strong momentum ahead.

AIC Mines Limited reported robust half-year results for December 2025, boosted by higher copper and gold prices despite weather-related sales disruptions. The company’s Jericho project and Eloise plant expansion remain on track, underpinning growth prospects.

Emeco Holdings Limited has reported a solid 15% increase in net profit for the half year ending December 2025, alongside a 9% rise in revenue, while opting to maintain a no-dividend payout policy.